Skip to contentS
Syra Health Corp
S
SYRASyra Health Corp Q3 2025 · 10-Q
Revenue$1.69M$1.69M−25.1% vs Q3 2024 Net Income-$225.90K-$225.90KN/M vs Q3 2024 EPS Diluted-$0.02-$0.02N/M vs Q3 2024 Gross Profit$554,541−17.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Syra Health Corp · CIK 1922335 · Engraved from SEC EDGAR
Operating Cash Flowderived-$244,308N/M Margins · derivedGross margin32.9%+3.2 pt vs Q3 2024
Operating margin-13.8%+5.3 pt vs Q3 2024
Net margin-13.4%+5.1 pt vs Q3 2024
ended Sep 30, 2025 · filed Nov 12, 2025 · 43 d after period end